ESMO 2020: New developments in the treatment of lung cancer
ESMO 2020: New developments in the treatment of lung cancer
SABCS 2020: Conference roundup
ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial
Latest data for managing ALK NSCLC patients
Pregnancy outcomes in breast cancer survivors; meta-analysis
Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk CLL
OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020
Five year update of ECHELON-1 for classical Hodgkin lymphoma
Real world management of multiple myeloma patients
Clinical implications of MRD detection in infants with KMT2A-rearranged ALL Treated on the Interfant-06 protocol
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia